About: Aytu BioPharma, Inc., a pharmaceutical company, focuses on commercializing novel therapeutics in the United States and internationally. The company offers prescription products for the treatment of attention deficit hyperactivity disorder (ADHD), including Adzenys XR-ODT extended-release orally disintegrating tablets for patients from six years of age and above; Cotempla XR-ODT A central nervous system stimulant indicated for the treatment of ADHD in patients 6 to 17 years of age; and Metadate CD, a central nervous system stimulant indicated for the treatment of ADHD in patients 6 to 15 years of age. It also provides pediatric prescription product portfolio comprising Karbinal ER, an extended-release carbinoxamine (antihistamine) suspension indicated to treat numerous allergic conditions for patients two years and above. The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu BioPharma, Inc. in March 2021. Aytu BioPharma, Inc. is headquartered in Denver, Colorado.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Latest price: $1.97 (-2.72%)
AYTU NASDAQ Aytu BioScience Inc
Aytu BioScience Inc share price
AYTU price activity
Last Price
$1.970
Change (24hr)
-0.06 USD (-2.72%)
Volume
22.95K
Volume (4w avg)
-
Open
$1.99
Day Range
$1.96 - $1.99
Previous Close
$2.03
Last Trade
12 Oct, 8:00 pm GMT+0
Delayed
12 Oct, 8:00 pm GMT+0
AYTU price performance
Delayed
12 Oct, 8:00 pm GMT+0
AYTU Market Signals